GlaxoSmithKline Pharmaceuticals Limited recommended a dividend of INR 90/- (including special dividend of INR 60) per equity share on face value of INR 10 each for the year ended 31 st March 2022, subject to approval of members at 97th Annual General Meeting to be held on 26th July, 2022. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed 8th July, 2022 as the Record Date for determining entitlement of members to final dividend for the financial year ended 31 st March, 2022. The dividend, if approved by the members will be paid on or after 27th July, 2022.